Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.

Myocardial infarction (MI), a leading cause of death around the world, displays a complex pattern of inheritance. When MI occurs early in life, genetic inheritance is a major component to risk. Previously, rare mutations in low-density lipoprotein (LDL) genes have been shown to contribute to MI risk...

Descripció completa

Dades bibliogràfiques
Autors principals:	Do, R, Stitziel, N, Won, H, Jørgensen, AB, Duga, S, Angelica Merlini, P, Kiezun, A, Farrall, M, Goel, A, Zuk, O, Guella, I, Asselta, R, Lange, L, Peloso, G, Auer, P, Girelli, D, Martinelli, N, Farlow, D, DePristo, M, Roberts, R, Stewart, A, Saleheen, D, Danesh, J, Epstein, SE, Sivapalaratnam, S
Format:	Journal article
Idioma:	English
Publicat:	2014

Ítems similars

Inactivating mutations in NPC1L1 and protection from coronary heart disease.
per: Stitziel, N, et al.
Publicat: (2014)

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
per: Lander, Eric Steven
Publicat: (2017)

Systematic cell-based phenotyping of missense alleles empowers rare variant association studies: a case for LDLR and myocardial infarction.
per: Aenne S Thormaehlen, et al.
Publicat: (2015-02-01)

Systematic Cell-Based Phenotyping of Missense Alleles Empowers Rare Variant Association Studies: A Case for LDLR and Myocardial Infarction
per: Thormaehlen, Aenne S., et al.
Publicat: (2015)

Loss-of-function mutations in APOC3, triglycerides, and coronary disease.
per: Crosby, J, et al.
Publicat: (2014)

Inflammation and skin cholesterol in LDLr−/−, apoA-I−/− mice: link between cholesterol homeostasis and self-tolerance?
per: Manal Zabalawi, et al.
Publicat: (2007-01-01)

Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia.
per: Stitziel, N, et al.
Publicat: (2013)

Exome Sequencing and Directed Clinical Phenotyping Diagnose Cholesterol Ester Storage Disease Presenting as Autosomal Recessive Hypercholesterolemia
per: Stitziel, N, et al.
Publicat: (2013)

Effects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian population
per: Ilaria Guella, et al.
Publicat: (2010-11-01)

ANGPTL3, ANGPTL4, APOA5, APOB, APOC2, APOC3, LDLR, PCSK9, LPL gene variants and coronary artery disease risk
per: A. N. Meshkov, et al.
Publicat: (2022-11-01)

Differential tissue-specific expression of human apoA-I and apoA-II
per: TL Eggerman, et al.
Publicat: (1991-05-01)

LDLR gene’s promoter region hypermethylation in patients with familial hypercholesterolemia
per: R. A. Zorzo, et al.
Publicat: (2023-06-01)

Computational and statistical approaches to analyzing variants identified by exome sequencing
per: Stitziel, Nathan O., et al.
Publicat: (2012)

Computational and statistical approaches to analyzing variants identified by exome sequencing
per: Stitziel, Nathan O., et al.
Publicat: (2012)

SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I–/– mice
per: Veneracion G. Cabana, et al.
Publicat: (1999-06-01)

Phenotypic characterization of genetically lowered human lipoprotein(a) levels
per: Emdin, C, et al.
Publicat: (2016)

ApoA-I and Cancer
per: Maryam eZamanian-Daryoush, et al.
Publicat: (2015-11-01)

Antibodies against electronegative LDL inhibit atherosclerosis in LDLr-/- mice
per: D.M. Grosso, et al.
Publicat: (2008-12-01)

Clinical characteristics of carriers of pathogenic LDLR and АРОВ mutations
per: Z. F. Kim, et al.
Publicat: (2024-02-01)

Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
per: Yanhua Wu, et al.
Publicat: (2016-01-01)

GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex
per: Mark A. Deeg, et al.
Publicat: (2001-03-01)

LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL
per: Kaihan Wang, et al.
Publicat: (2024-03-01)

Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions
per: Elvezia Maria Paraboschi, et al.
Publicat: (2018-12-01)

SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism
per: Maria C. de Beer, et al.
Publicat: (2005-10-01)

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
per: Kuang-Yuh eChyu, et al.
Publicat: (2015-09-01)

ApoA-II kinetics in humans using endogenous labeling with stable isotopes: slower turnover of apoA-II compared with the exogenous radiotracer method
per: K Ikewaki, et al.
Publicat: (1996-02-01)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
per: Ma S, et al.
Publicat: (2019-08-01)

A dual-reporter LDLR system integrating fluorescence and luminescence for understanding LDLR regulation and facilitating drug discovery
per: Peng Jiao, et al.
Publicat: (2025-03-01)

Targeting the Apoa1 locus for liver-directed gene therapy
per: Marco De Giorgi, et al.
Publicat: (2021-06-01)

Therapies to Increase ApoA-I and HDL-Cholesterol Levels
per: William M. Brown J.D., Ph.D., et al.
Publicat: (2008-01-01)

Sexual dimorphism in atherosclerotic plaques of aged Ldlr −/− mice
per: Virginia Smit, et al.
Publicat: (2024-05-01)

First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features
per: Letizia Straniero, et al.
Publicat: (2018-10-01)

Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia
per: Jian Wang, et al.
Publicat: (2005-02-01)

ApoA-I mimetics: tomatoes to the rescue1
per: Godfrey S. Getz, et al.
Publicat: (2013-04-01)

The enigma of soluble LDLR: could inflammation be the key?
per: Majambu Mbikay, et al.
Publicat: (2020-02-01)

ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis[S]
per: Yaoyong Wang (王耀勇), et al.
Publicat: (2011-08-01)

Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
per: Kelli A Lytle, et al.
Publicat: (2016-01-01)

Effect of ethanol on the synthesis and secretion of apoA-I- and apoB-containing lipoproteins in HepG2 cells
per: N Dashti, et al.
Publicat: (1996-04-01)

Genes of APOA5 and APOH apoliproteins as regulators of lipoprotein metabolism
per: N. S. Shirokova, et al.
Publicat: (2020-09-01)

Polimorfismos de los genes LEP, LDLR, APOA4 y sus relaciones con el sobrepeso, la obesidad y el riesgo de enfermedades crónicas en adultos del estado Sucre, Venezuela
per: Greta Rodríguez-Arroyo, et al.
Publicat: (2016-03-01)